Request For Customization Market Study on ESR1 Mutated Metastatic Breast Cancer Diagnostics: PMR Foresees Various Opportunities with Advances in Precision Medicine, Growing Prevalence of Metastatic Breast Cancer Cases, and Growing Emphasis on Personalized Treatment Approaches